20:35 , Jan 6, 2017 |  BC Week In Review  |  Company News

Medigene, 2A Pharma deal

Medigene granted 2A Pharma exclusive worldwide rights to develop and commercialize Medigene's preclinical adeno-associated virus-like particles (AAVLPs). Medigene is eligible to receive clinical, regulatory and commercial milestones, plus royalties. Medigene said it and 2A Pharma...